Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02161211 · ClinicalTrials.gov registry record · NA
Dismantling the Components and Dosing of CBT for Co-Occurring Disorders
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT02161211: Completed NA study, sponsored by University of Minnesota.
NCT02161211 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02161211, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purpose of this study is to establish a brief CBT intervention that can largely, if not fully eliminate the deleterious effect of common co-occurring anxiety disorders on alcohol use disorder treatment outcomes.
Primary Outcome
Relapse status will be assessed using categorical relapse status (yes vs. no). Count is of those who relapsed
Interventions
- BEHAVIORAL Combined
- BEHAVIORAL De-coupling
- BEHAVIORAL Anxiety Reduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2014-07 |
| Est. Completion | 2020-06-19 |
| Phase | NA |
What the finished NCT02161211 record still lists
NCT02161211 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 3 interventions - of which Combined is the first listed.
NCT02161211 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02161211 about?
NCT02161211 is a clinical study titled "Dismantling the Components and Dosing of CBT for Co-Occurring Disorders". The purpose of this study is to establish a brief CBT intervention that can largely, if not fully eliminate the deleterious effect of common co-occurring anxiety disorders on alcohol use disorder treatment outcomes.
What is the current status of trial NCT02161211?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2014-07. Estimated completion is 2020-06-19.
What interventions are being tested in trial NCT02161211?
The interventions under investigation include: Combined (BEHAVIORAL), De-coupling (BEHAVIORAL), Anxiety Reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT02161211?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02161211's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia